Precigen PGEN Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Regeneron PharmaceuticalsREGN

$266.8M+13.8%

Allogene TherapeuticsALLO

$81.05M-8.9%

Opko HealthOPK

$44.99M-4.7%

Arrowhead ResearchARWR

$107.88M-5.6%

FAQ

What is Precigen's operating lease liabilities (total)?

Precigen (PGEN) reported operating lease liabilities (total) of $4.73M in Q1 2026.

How has Precigen's operating lease liabilities (total) changed year-over-year?

Precigen's operating lease liabilities (total) decreased by 12.7% year-over-year, from $5.42M to $4.73M.

What is the long-term trend for Precigen's operating lease liabilities (total)?

Over 5 years (2020 to 2025), Precigen's operating lease liabilities (total) has grown at a -13.2% compound annual growth rate (CAGR), from $10.4M to $5.12M.

What does operating lease liabilities (total) mean?

This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.